October 1, 2020

The Niche

Knoepfler lab stem cell blog

Academia Japan iPS cells

3 min read

Stem cell technology is poised to wow the world with biomedical advances in the coming decades. Japan wants to lead the way, particularly with applications that focus on a relatively new kind of stem cells called induced pluripotent stem cells or iPS cells. Japanese researcher, Shinya Yamanaka, first reported production of iPS cells in 2006 in mice and in 2007 in humans. Japan has raced ahead of other countries and they appear to have the intellectual property rights and drive to do so. And …Read More

1 min read

I’ve been researching the issue of how intellectual property (IP) and patents to induced pluripotent stem (iPS) cell will influence the field. It’s a complicated, worrisome picture in terms of getting this technology to patients to help them. I’m concerned there may be an all out patent war. Even for those who do not go to court or challenge each other’s iPS cell patents, but choose instead to go the licensure route, things are troubling. The organization in the driver’s seat is called iPS …Read More